These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9354574)

  • 21. Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass.
    Hunt BJ; Segal HC; Yacoub M
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):211-2. PubMed ID: 1377315
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of heparin-coated circuits with full heparin dose strategy.
    Sinci V; Kalaycioglu S; Gunaydin S; Imren Y; Gokgoz L; Soncul H; Ersoz A
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin concentrations in neonates during cardiopulmonary bypass.
    Davidson SJ; Tillyer ML; Keogh J; Hall J; Kelleher AA
    J Thromb Haemost; 2012 Apr; 10(4):730-2. PubMed ID: 22329742
    [No Abstract]   [Full Text] [Related]  

  • 24. Con: heparin-bonded cardiopulmonary bypass circuits do not represent a desirable and cost-effective advance in cardiopulmonary bypass technology.
    Woolf RL; Mythen MG
    J Cardiothorac Vasc Anesth; 1998 Dec; 12(6):710-2. PubMed ID: 9854674
    [No Abstract]   [Full Text] [Related]  

  • 25. [Safety of continuous epidural anesthesia during heart surgery--change of coagulation-fibrinolysis under heparinization].
    Maeda M; Kosaka Y; Kushizaki H; Yamamori Y; Hashimoto K; Saito Y
    Masui; 1999 Jul; 48(7):723-30. PubMed ID: 10434512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro: heparin-bonded circuits represent a desirable option for cardiopulmonary bypass.
    Shore-Lesserson L
    J Cardiothorac Vasc Anesth; 1998 Dec; 12(6):705-9. PubMed ID: 9854673
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cardiopulmonary bypass and blood coagulation].
    Kitaguchi K; Furuie H
    Masui; 2001 Dec; 50 Suppl():S115-20. PubMed ID: 11871083
    [No Abstract]   [Full Text] [Related]  

  • 28. Pro and con of heparin-bonded circuits for cardiopulmonary bypass.
    Weiss BM; von Segesser LK
    J Cardiothorac Vasc Anesth; 1999 Oct; 13(5):646-52. PubMed ID: 10527241
    [No Abstract]   [Full Text] [Related]  

  • 29. [Heparin management by activated coagulation time during cardiopulmonary bypass].
    Shikano K; Shinpo H; Nasu M; Morimoto T; Suzuki T; Yada I; Kusagawa M
    Kyobu Geka; 1981; 34(12):934-7. PubMed ID: 7349352
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticoagulation policy during use of aprotinin in cardiopulmonary bypass.
    van Oeveren W; van Oeveren B; Wildevuur CR
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):210-1. PubMed ID: 1377314
    [No Abstract]   [Full Text] [Related]  

  • 31. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
    de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C
    Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members.
    Sniecinski RM; Bennett-Guerrero E; Shore-Lesserson L
    Anesth Analg; 2019 Aug; 129(2):e41-e44. PubMed ID: 30540616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.
    Kreisler KR; Vance RA; Cruzzavala J; Mahnken JD
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):608-11. PubMed ID: 16202894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation, fibrinolysis, and cell activation in patients and in shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface.
    Baufreton C; de Brux JL
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2116. PubMed ID: 14688752
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of three methods to estimate heparin loading dose for cardiopulmonary bypass.
    Clark TD; Ecklund JM; McCall MM; Wolk DR; Riley JB
    J Extra Corpor Technol; 1996 Jun; 28(2):67-70. PubMed ID: 10160446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
    Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
    [No Abstract]   [Full Text] [Related]  

  • 38. Pre-operative heparin reduces pulmonary microvascular fibrin deposition following cardiac surgery.
    Dixon B; Opeskin K; Stamaratis G; Nixon I; Yi M; Newcomb AE; Rosalion A; Zhang Y; Santamaria JD; Campbell DJ
    Thromb Res; 2011 Jan; 127(1):e27-30. PubMed ID: 20923713
    [No Abstract]   [Full Text] [Related]  

  • 39. Inaccuracy of coagulation studies performed on blood samples obtained from arterial catheter.
    Akinci SB; Salman N; Aykut T; Kanbak M; Aypar U
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):702-3. PubMed ID: 16202916
    [No Abstract]   [Full Text] [Related]  

  • 40. A case report of heparin resistance due to acquired antithrombin III deficiency.
    Leong CK; Ong BC
    Ann Acad Med Singap; 1998 Nov; 27(6):877-9. PubMed ID: 10101569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.